Psychological Profiles and Personality Traits Linked to Central Serous Chorioretinopathy Risk
Type A personality traits linked to central serous chorioretinopathy
A meta-analysis identifies a significant link between Type A behavior and central serous chorioretinopathy, suggesting psychological factors…
A large study links Type A behaviors, like high competitiveness and time urgency, to a specific eye condition called central serous choriore…
Photodynamic therapy provides superior visual gains and faster fluid resolution in acute central serous chorioretinopathy
Photodynamic therapy shows better results for central serous chorioretinopathy
This meta-analysis of 464 eyes evaluated photodynamic therapy (PDT) and anti-VEGF agents for acute central serous chorioretinopathy. The stu…
Photodynamic therapy helps patients with central serous chorioretinopathy see better and clear fluid faster than anti-VEGF treatments.
Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases
Stress and hormones may play a role in eye health
This narrative literature overview of 35 studies synthesizes the role of glucocorticoid signaling and stress-related neuroendocrine dysregul…
New research suggests that stress-related hormone changes could influence conditions like glaucoma and other serious eye diseases.
Systemic C-reactive protein levels show no significant association with central serous chorioretinopathy
CRP Levels Show No Link to Central Serous Chorioretinopathy
This meta-analysis of 544 patients with CSC and 655 controls found no statistically significant difference in systemic CRP levels (95% CI: -…
New analysis suggests that systemic C-reactive protein levels are not linked to the eye condition central serous chorioretinopathy.
Seasonal variation linked to central serous chorioretinopathy incidence
Spring and autumn bring higher risk of central serous chorioretinopathy in working-age men
A meta-analysis found significantly higher CSC incidence in spring and autumn compared to summer, suggesting seasonal patterns in working-ag…
Working-age men face higher rates of central serous chorioretinopathy in spring and autumn compared to summer, according to a new analysis o…
GWAS meta-analysis identifies 10 CSC loci and links genetic risk to OCT abnormalities
Genetic clues point to new pathways for Central Serous Chorioretinopathy
This meta-analysis of GWAS data from European-ancestry cohorts identified 10 genome-wide significant loci for central serous chorioretinopat…
A massive genetic study finds specific DNA spots linked to Central Serous Chorioretinopathy, offering new targets for future treatment resea…
Systematic review and meta-analysis links pregnancy to higher risk of central serous chorioretinopathy
Pregnancy increases risk of central serous chorioretinopathy by more than five times
This systematic review and meta-analysis evaluates the association between pregnancy and central serous chorioretinopathy (CSC) using data f…
A large review found pregnancy raises the risk of central serous chorioretinopathy significantly. This matters for expectant mothers and doc…
Brolucizumab Protocol for Chronic Central Serous Chorioretinopathy Compared to Multivitamins
Doctors test new eye drug for stubborn fluid without neovascularization
This protocol describes a randomized controlled trial comparing intravitreal brolucizumab to oral multivitamins in 42 patients with chronic …
A new eye drug trial could help people with stubborn fluid in their retina by comparing it to vitamins in a strict study.
Questions about central serous chorioretinopathy
How does brolucizumab compare to multivitamins for treating chronic central serous chorioretinopathy?
Clinical trials are currently investigating whether brolucizumab is more effective than multivitamins for resolving fluid in the eye caused by chronic central serous chorioretinopathy.
Full answer →